visiongain Logo.png
Inhalation & Nasal Spray Generic Drugs Market at CAGR of 8.29% by 2031: Visiongain Research Inc.
17 juin 2021 12h30 HE | Visiongain Ltd
Visiongain has published a new report on Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031. Profiles of Inhalation & Nasal Spray Generic Drugs and Forecasts By Drug Class...
TIP_link_300x300.jpg
Generic Oncology Drugs Market Growth Sturdy at 6.3% CAGR to Outstrip $36,029.60 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
16 juin 2021 08h10 HE | The Insight Partners
Pune, India., June 16, 2021 (GLOBE NEWSWIRE) -- Generic Oncology Drugs Market: Key InsightsAccording to our new research study on “Generic Oncology Drugs Market to 2027 – Global Analysis and...
logo long.jpg
Saudi Arabia Pharmaceutical Drugs Market to Surpass US$ 16,663.1 Million by 2027, Says Coherent Market Insights (CMI)
23 avr. 2021 08h30 HE | CMI
SEATTLE, April 23, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the Saudi Arabia pharmaceutical drugs market is estimated to be valued at US$ 10,191.4 million in 2020 and is...
ARC logo.png
Generic Drugs Market Value Predicted To Reach US$ 627.6 Billion By 2027: Acumen Research And Consulting
01 avr. 2021 12h15 HE | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Generic Drugs Market – Global Industry Analysis, Market Size, Opportunities and...
Hausfeld logo
Celgene Rescinds Agreement to Compensate Cancer Patients Days Before Christmas
08 janv. 2020 13h36 HE | Hausfeld
WASHINGTON, Jan. 08, 2020 (GLOBE NEWSWIRE) -- On December 23, 2019, Celgene backed out of a settlement in which it had agreed to pay $55 million to end payors (consumers, insurers, union health and...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Enters into Strategic Marketing Alliance with Lannett For Generic Adderall®
11 mars 2019 06h45 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) announced today that it has entered into a license, supply, and distribution...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information
11 févr. 2019 17h34 HE | Elite Pharmaceuticals, Inc.
Conference Call Scheduled for Tuesday, February 12th at 11:30 AM EST NORTHVALE, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019
07 févr. 2019 06h00 HE | Elite Pharmaceuticals, Inc.
Northvale, NJ, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
SunGen Pharma.jpg
SunGen Pharma Receives Its Second and Third ANDA Approval from US FDA
11 déc. 2018 07h30 HE | SunGen Pharma LLC
PRINCETON, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
SunGen Pharma.jpg
SunGen Pharma Receives US FDA Approval for Prednisone ANDA
10 déc. 2018 12h28 HE | SunGen Pharma LLC
PRINCETON, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...